ASML jumps on hopes it will be spared in next round of China chip fight
Adds analyst comment, updates shares, background
By Toby Sterling
AMSTERDAM, July 31 (Reuters) -Shares in ASML ASML.AS, the largest maker of equipment used to manufacture computer chips, jumped on Wednesday following a Reuters report that signalled it may be spared many of the new U.S. restrictions being considered on exports to China.
The report said the U.S. would exclude allies including the Netherlands, where ASML is based, from new restrictions on equipment sales to half a dozen Chinese chipmaking plants.
ASML shares were up 5.6% at 855.20 at 0955 GMT.
"Today's news ... definitely alleviates the market's concerns as ASML had nearly half of sales from China in the first half of 2024," said Mizuho Securities analyst Kevin Wang.
The share price surge in Europe's biggest tech firm, with a market capitalisation of more than 300 billion euros ($325 billion), is the latest example of trade policy and political moves affecting stocks, rather than earnings or business plans.
Wednesday's rise reverses part of a large drop on July 17 following a Bloomberg report that the U.S. was considering unilateral action to restrict equipment exports by allies - including the Netherlands.
That obscured largely positive second quarter earnings from ASML that featured growing orders for its most advanced equipment from key customer TSMC 2330.TW amid the AI boom.
"We believe strong demand and tight capacity for advanced nodes in logic (computer chips) will drive more orders for ASML in the coming quarters," Wang said.
ASML and the Dutch government declined to comment.
ASML has a dominant position in lithography, the step of the chipmaking process in which the tiny circuitry of chips is created. U.S.-led restrictions on exports to China imposed since 2020 now cover much of the company's product range, but more limitations remain possible.
The company says that while its technology leadership remains intact, its sales will grow along with the semiconductor industry, regardless of where chips are made.
But around 20% of ASML's current order backlog is for sales of its older product lines to China and theoretically vulnerable to changes to policy in the short run.
Sales to China were a key support to ASML over the past 18 months, when Chinese firms snapped up equipment and few new plants in other regions began producing chips.
That should reverse 2025-2026 as new plants come on line in Taiwan, South Korea, the United States and in Europe, many with support from the U.S. "Chips Act" and similar programmes in other countries.
($1 = 0.9238 euros)
Reporting by Toby Sterling
Editing by Mark Potter
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
